Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Antibody Drug Conjugates Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global antibody drug conjugates market size reached US$ 5.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 18.5 Billion by 2027, exhibiting a growth rate (CAGR) of 23.8% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Antibody drug conjugates (ADCs) are highly potent biological drugs comprising tumor-targeting antibodies, which are chemically attached to a cytotoxic effector molecule. They deliver cytotoxic anticancer agents to affected cells by connecting them to monoclonal antibodies (mAb) through biodegradable linkers and allowing sensitive bifurcation between healthy and diseased tissues. They assist in increasing the cell-killing potential of mAb, enhancing drug tolerability, and limiting systematic exposure compared to standard chemotherapy bioactive compounds. At present, they are administered intravenously into the bloodstream to avoid gastric acid and proteolytic enzyme degradation of the mAb.

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Antibody Drug Conjugates Market Trends:

Due to sedentary lifestyles and the rising number of individuals who smoke and drink regularly, there is an increase in the prevalence of cancer around the world. This, in confluence with the escalating demand for cost-effective and successful cancer treatments, represents one of the key factors bolstering the growth of the market. Apart from this, the existing linkers often release payloads nonspecifically and lead to off-target toxicity, which severely affects the development of ADCs. As a result, leading players are continuously funding their research and development (R&D) projects to optimize the existing chemical triggers and develop novel chemical triggers to generate highly selective linkers. They are also coming up with novel linker-antibody attachments to produce stable and homogenous ADCs and additional linker-payload attachments to allow the expansion of payloads. Moreover, they are focusing on improving the absorption, distribution, metabolism, and excretion, which is creating a favorable market outlook. Other major factors, including considerably improving healthcare infrastructure, increasing awareness about therapies available for cancer treatments, and the introduction of cleavable linker technology, are anticipated to propel the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global antibody drug conjugates market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on component, target, application and end user.

Breakup by Component:

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Monoclonal Antibodies
  • Linker
  • Cytotoxic Agent
  • Others
     

Breakup by Target:

  • Antibody-Protein Toxin Conjugates
  • Antibody-Chelated Radionuclide Conjugates
  • Antibody-Small-Molecule Drug Conjugates
  • Antibody-Enzyme Conjugates
     

Breakup by Application:

  • Lymphoma
  • Ovarian Cancer
  • Lung Cancer
  • Breast Cancer
  • Brain Tumor
  • Others
     

Breakup by End User:

  • Hospitals
  • Specialized Cancer Centers
  • Academic Research Institutes
  • Biotechnology Companies
  • Others
     

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being ADC Therapeutics SA, Astellas Pharma Inc., AstraZeneca plc, Celldex Therapeutics Inc., F. Hoffmann-La Roche AG, Gilead Sciences Inc., GlaxoSmithKline Plc, ImmunoGen Inc, Pfizer Inc., Sanofi S.A., Seagen Inc., Sorrento Therapeutics Inc. and Takeda Pharmaceutical Company Ltd.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Component, Target, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered ADC Therapeutics SA, Astellas Pharma Inc., AstraZeneca plc, Celldex Therapeutics Inc., F. Hoffmann-La Roche AG, Gilead Sciences Inc., GlaxoSmithKline Plc, ImmunoGen Inc, Pfizer Inc., Sanofi S.A., Seagen Inc., Sorrento Therapeutics Inc. and Takeda Pharmaceutical Company Ltd.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global antibody drug conjugates market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global antibody drug conjugates market?
  • What are the key regional markets?
  • What is the breakup of the market based on the component?
  • What is the breakup of the market based on the target?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global antibody drug conjugates market and who are the key players?
  • What is the degree of competition in the industry?

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Antibody Drug Conjugates Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Component
    6.1    Monoclonal Antibodies
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Linker
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Cytotoxic Agent
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Others
        6.4.1 Market Trends
        6.4.2 Market Forecast
7   Market Breakup by Target
    7.1    Antibody-Protein Toxin Conjugates
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Antibody-Chelated Radionuclide Conjugates
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Antibody-Small-Molecule Drug Conjugates
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Antibody-Enzyme Conjugates
        7.4.1 Market Trends
        7.4.2 Market Forecast
8   Market Breakup by Application
    8.1    Lymphoma
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Ovarian Cancer
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Lung Cancer
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Breast Cancer
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Brain Tumor
        8.5.1 Market Trends
        8.5.2 Market Forecast
    8.6    Others
        8.6.1 Market Trends
        8.6.2 Market Forecast
9   Market Breakup by End User
    9.1    Hospitals
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Specialized Cancer Centers
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Academic Research Institutes
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Biotechnology Companies
        9.4.1 Market Trends
        9.4.2 Market Forecast
    9.5    Others
        9.5.1 Market Trends
        9.5.2 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    ADC Therapeutics SA
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
        15.3.2    Astellas Pharma Inc.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    AstraZeneca plc
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    Celldex Therapeutics Inc.
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
           15.3.4.4 SWOT Analysis
        15.3.5    F. Hoffmann-La Roche AG
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
        15.3.6    Gilead Sciences Inc.
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    GlaxoSmithKline Plc
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    ImmunoGen Inc
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Pfizer Inc.
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Sanofi S.A.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    Seagen Inc.
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials
           15.3.11.4 SWOT Analysis
        15.3.12    Sorrento Therapeutics Inc.
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio
           15.3.12.3 Financials
        15.3.13    Takeda Pharmaceutical Company Ltd.
           15.3.13.1 Company Overview
           15.3.13.2 Product Portfolio
           15.3.13.3 Financials
           15.3.13.4 SWOT Analysis

List of Figures

Figure 1: Global: Antibody Drug Conjugates Market: Major Drivers and Challenges
Figure 2: Global: Antibody Drug Conjugates Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Antibody Drug Conjugates Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Antibody Drug Conjugates Market: Breakup by Component (in %), 2021
Figure 5: Global: Antibody Drug Conjugates Market: Breakup by Target (in %), 2021
Figure 6: Global: Antibody Drug Conjugates Market: Breakup by Application (in %), 2021
Figure 7: Global: Antibody Drug Conjugates Market: Breakup by End User (in %), 2021
Figure 8: Global: Antibody Drug Conjugates Market: Breakup by Region (in %), 2021
Figure 9: Global: Antibody Drug Conjugates (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Antibody Drug Conjugates (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Antibody Drug Conjugates (Linker) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Antibody Drug Conjugates (Linker) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Antibody Drug Conjugates (Cytotoxic Agent) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Antibody Drug Conjugates (Cytotoxic Agent) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Antibody Drug Conjugates (Other Components) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Antibody Drug Conjugates (Other Components) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Antibody Drug Conjugates (Antibody-Protein Toxin Conjugates) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Antibody Drug Conjugates (Antibody-Protein Toxin Conjugates) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Antibody Drug Conjugates (Antibody-Chelated Radionuclide Conjugates) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Antibody Drug Conjugates (Antibody-Chelated Radionuclide Conjugates) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Antibody Drug Conjugates (Antibody-Small-Molecule Drug Conjugates) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Antibody Drug Conjugates (Antibody-Small-Molecule Drug Conjugates) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Antibody Drug Conjugates (Antibody-Enzyme Conjugates) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Antibody Drug Conjugates (Antibody-Enzyme Conjugates) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Antibody Drug Conjugates (Lymphoma) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Antibody Drug Conjugates (Lymphoma) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Antibody Drug Conjugates (Ovarian Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Antibody Drug Conjugates (Ovarian Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Antibody Drug Conjugates (Lung Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Antibody Drug Conjugates (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Antibody Drug Conjugates (Breast Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Antibody Drug Conjugates (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Antibody Drug Conjugates (Brain Tumor) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Antibody Drug Conjugates (Brain Tumor) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Antibody Drug Conjugates (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Antibody Drug Conjugates (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Antibody Drug Conjugates (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Antibody Drug Conjugates (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Antibody Drug Conjugates (Specialized Cancer Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Antibody Drug Conjugates (Specialized Cancer Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Global: Antibody Drug Conjugates (Academic Research Institutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Global: Antibody Drug Conjugates (Academic Research Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Global: Antibody Drug Conjugates (Biotechnology Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Global: Antibody Drug Conjugates (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Global: Antibody Drug Conjugates (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Global: Antibody Drug Conjugates (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: North America: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: North America: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: United States: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: United States: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Canada: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Canada: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Asia-Pacific: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Asia-Pacific: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: China: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: China: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Japan: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Japan: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: India: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: India: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: South Korea: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: South Korea: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Australia: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Australia: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Indonesia: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Indonesia: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Others: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Others: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Europe: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Europe: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Germany: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Germany: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: France: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: France: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: United Kingdom: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: United Kingdom: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Italy: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Italy: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Spain: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Spain: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Russia: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Russia: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Others: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Others: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Latin America: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Latin America: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Brazil: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Brazil: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Mexico: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2016 & 2021
Figure 90: Mexico: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 91: Others: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2016 & 2021
Figure 92: Others: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 93: Middle East and Africa: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2016 & 2021
Figure 94: Middle East and Africa: Antibody Drug Conjugates Market: Breakup by Country (in %), 2021
Figure 95: Middle East and Africa: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 96: Global: Antibody Drug Conjugates Industry: SWOT Analysis
Figure 97: Global: Antibody Drug Conjugates Industry: Value Chain Analysis
Figure 98: Global: Antibody Drug Conjugates Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Antibody Drug Conjugates Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Antibody Drug Conjugates Market Forecast: Breakup by Component (in Million US$), 2022-2027
Table 3: Global: Antibody Drug Conjugates Market Forecast: Breakup by Target (in Million US$), 2022-2027
Table 4: Global: Antibody Drug Conjugates Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Antibody Drug Conjugates Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Antibody Drug Conjugates Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Antibody Drug Conjugates Market: Competitive Structure
Table 8: Global: Antibody Drug Conjugates Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links